Glucagon-like peptide (GLP)-1 analogues as an add-on to insulin for adults with type 1 diabetes mellitus-Reference-Cited by-同舟云学术

Glucagon-like peptide (GLP)-1 analogues as an add-on to insulin for adults with type 1 diabetes mellitus

Published:2018-11-01 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Yamada Tomohide¹,Mori Rintaro²,Hosoe Jun¹,Shojima Nobuhiro¹,Kamata Ryuichi¹,Ishinohachi Kotomi¹,Yamauchi Toshimasa¹,Tanikawa Yukihiro³,Kadowaki Takashi⁴

Affiliation:

1. Graduate School of Medicine, The University of Tokyo; Department of Diabetes and Metabolic Diseases; 7-3-1, Hongo, Bunkyo-ku Tokyo Japan 113-8655

2. National Center for Child Health and Development; Department of Health Policy; 2-10-1 Okura Setagaya-ku Tokyo Tokyo Japan 157-0074

3. Kyoto University Graduate School of Medicine / School of Public Health; Department of Healthcare Epidemiology; Yoshida Konoe-Cho, Sakyoku Kyoto Kyoto Prefecture Japan 606-8501

4. University of Tokyo; Department of Prevention of Diabetes and Lifestyle-related Diseases; 7-3-1, Hongo, Bunkyo-ku Tokyo Tokyo Japan 113-8655

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013164/epdf/full

Reference78 articles.

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus;Expert Committee on the Diagnosis and Classification of Diabetes Mellitus;Diabetes Care,2003

2. Standards of medical care in diabetes - 2008;American Diabetes Association;Diabetes Care,2008

3. Standards of medical care in diabetes - 2017;American Diabetes Association;Diabetes Care,2017

4. Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial;Ahrén;Diabetes Care,2016

5. Interaction revisited: the difference between two estimates;Altman;BMJ,2003